Amryt Pharma plc (LON:AMYT – Get Free Report)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 143 ($1.84) and traded as high as GBX 155 ($1.99). Amryt Pharma shares last traded at GBX 143 ($1.84), with a volume of 90,726 shares trading hands.
Amryt Pharma Price Performance
The company has a quick ratio of 1.14, a current ratio of 1.80 and a debt-to-equity ratio of 66.05. The company has a market cap of £457.11 million and a PE ratio of -4.33. The stock has a 50-day simple moving average of GBX 143 and a 200 day simple moving average of GBX 143.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Read More
- Five stocks we like better than Amryt Pharma
- 3 Small Caps With Big Return Potential
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- 3 REITs to Buy and Hold for the Long Term
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- The Role Economic Reports Play in a Successful Investment Strategy
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
